Beneficial IFN-α treatment of tumorous herpes simplex blepharoconjunctivitis in dedicator of cytokinesis 8 deficiency-Reference-Cited by-同舟云学术

Beneficial IFN-α treatment of tumorous herpes simplex blepharoconjunctivitis in dedicator of cytokinesis 8 deficiency

Published:2014-05 Issue:5 Volume:133 Page:1456-1458
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Papan Cihan,Hagl Beate,Heinz Valerie,Albert Michael H.,Ehrt Oliver,Sawalle-Belohradsky Julie,Neumann Jens,Ries Martin,Bufler Philip,Wollenberg Andreas,Renner Ellen D.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference17 articles.

1. Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity;Renner;J Pediatr,2004

2. Combined immunodeficiency associated with DOCK8 mutations;Zhang;N Engl J Med,2009

3. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome;Engelhardt;J Allergy Clin Immunol,2009

4. DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation;Jabara;Nat Immunol,2012

5. Defective actin accumulation impairs human natural killer cell function in patients with dedicator of cytokinesis 8 deficiency;Mizesko;J Allergy Clin Immunol,2013

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Successfully treated with siltuximab and prednisone in a 7-year-old girl with DOCK8-deficiency presenting as recurrent wart-like lesions: a case report;Frontiers in Immunology;2024-07-09

2. Phenotypic and Genotypic Spectrum of Children with Autosomal Recessive Hyperimmunoglobulin E Syndrome Caused by DOCK8 Mutation: A Systematic Review of Case Reports;Indian Pediatrics Case Reports;2024-07

3. Viral infections and inborn errors of immunity;Current Opinion in Infectious Diseases;2024-05-14

4. Inmunodeficiencia combinada debida a deficiencia de DOCK8. Lo que sabemos hasta ahora;Revista Alergia México;2023-01-31